| 前收市價 | 235.40 |
| 開市 | 234.70 |
| 買盤 | 233.80 x 0 |
| 賣出價 | 234.00 x 0 |
| 今日波幅 | 232.50 - 236.30 |
| 52 週波幅 | 174.20 - 268.80 |
| 成交量 | |
| 平均成交量 | 720,667 |
| 市值 | 64.116B |
| Beta 值 (5 年，每月) | 0.56 |
| 市盈率 (最近 12 個月) | 28.01 |
| 每股盈利 (最近 12 個月) | 8.30 |
| 業績公佈日 | 2024年7月18日 |
| 遠期股息及收益率 | 4.40 (1.87%) |
| 除息日 | 2024年4月23日 |
| 1 年預測目標價 | 260.56 |
- Reuters
UPDATE 2-US FDA advises healthcare facilities to switch from Getinge's heart devices
The U.S Food and Drug Administration (FDA) on Wednesday advised healthcare facilities to move away from using Getinge's heart devices in patients as they faced safety and quality concerns despite a string of recalls. Getinge did not immediately respond to a Reuters request for comment. The FDA suggests providers to move away from the use of Getinge's Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump (IABP) devices and its Cardiohelp system and HLS Sets.
